Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,753 | -5,165 | -19,030 |
| Depreciation Amortization | 1,654 | 977 | 2,310 |
| Accounts receivable | -53 | -236 | N/A |
| Accounts payable and accrued liabilities | 5 | -395 | N/A |
| Other Working Capital | 109 | -878 | 520 |
| Other Operating Activity | 31 | 724 | 1,250 |
| Operating Cash Flow | $-9,007 | $-4,973 | $-14,950 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -7,000 | -6,997 | N/A |
| PPE Investments | -72 | -33 | -2,010 |
| Other Investing Activity | 0 | 0 | -7,500 |
| Investing Cash Flow | $-7,072 | $-7,030 | $-9,510 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 10,000 | 10,000 | N/A |
| Debt Repayment | -10,930 | -10,575 | N/A |
| Common Stock Issued | 9,905 | 9,903 | N/A |
| Other Financing Activity | 397 | 406 | 13,130 |
| Financing Cash Flow | $9,372 | $9,734 | $13,130 |
| Beginning Cash Position | 11,947 | 11,947 | 23,280 |
| End Cash Position | 5,240 | 9,678 | 11,940 |
| Net Cash Flow | $-6,707 | $-2,269 | $-11,330 |
| Free Cash Flow | |||
| Operating Cash Flow | -9,007 | -4,973 | -14,950 |
| Capital Expenditure | -72 | -33 | N/A |
| Free Cash Flow | -9,079 | -5,006 | -14,950 |